Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
04/24/2014 | US20140112901 Stable compositions containing thrombin and methods for preparation and use thereof |
04/24/2014 | US20140112896 Methods and compositions for the provision of proteins deficient in lysosomal storage diseases |
04/24/2014 | US20140112888 Viral Hepatitis Treatment |
04/24/2014 | US20140112885 Antiviral compounds |
04/24/2014 | US20140112882 Methods to treat pancreatic inflammation and associated lung injury through regulation of pancreatic interleukin-22 expression |
04/24/2014 | DE112012002928T5 Anwendungsverfahren von aktivierten funktionellen Proteinen zur Verbesserung der Tiergesundheit Application method of activated functional proteins to improve animal health |
04/23/2014 | EP2722339A1 Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation |
04/23/2014 | EP2722054A1 Methods and compositions for oral administration of proteins |
04/23/2014 | EP2722053A1 Antibacterial agent for treating infectious diseases of bacterial origin |
04/23/2014 | EP2722052A1 Methods For Attenuating Release Of Inflammatory Mediators And Peptides Useful Therein |
04/23/2014 | EP2722051A1 Monomethylvaline compounds having phenylalanine side-chain modifications at the C-terminus |
04/23/2014 | EP2721073A1 Soluble proteins for use as therapeutics |
04/23/2014 | EP2721063A1 Pcsk9-binding polypeptides and methods of use |
04/23/2014 | EP2721062A1 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
04/23/2014 | EP2721061A1 Stabilized variant maml peptides and uses thereof |
04/23/2014 | EP2721054A1 Modified antibiotic peptides having variable systemic release |
04/23/2014 | EP2720754A2 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
04/23/2014 | EP2720713A2 Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme |
04/23/2014 | EP2720712A2 Stable formulations of a hyaluronan-degrading enzyme |
04/23/2014 | EP2720711A1 Multi substituted insulins |
04/23/2014 | EP2720710A1 Freeze-dried formulations of fgf-18 |
04/23/2014 | EP2720709A1 Ciliary neurotrophic factor variants |
04/23/2014 | EP2720708A2 Targeting the neuromuscular junction for treatment |
04/23/2014 | EP2720707A2 Anti-inflammatory pharmaceutical products |
04/23/2014 | EP2720706A2 Group a streptococcus multivalent vaccine |
04/23/2014 | EP2720705A2 Compositions targeting pkc-theta and uses and methods of treating pkc-theta pathologies, adverse immune responses and diseases |
04/23/2014 | EP2720704A2 Aromatic-cationic peptides and uses of same |
04/23/2014 | EP2720703A1 Methods for increasing insulin sensitivity and treating diabetes |
04/23/2014 | EP2720690A1 Combined chemical modification of sphingosine-1-phosphate (s1p) and cxcr4 signalling pathways for hematopoietic stem cell (hsc) mobilization and engraftment |
04/23/2014 | EP2720688A1 High capacity diketopiperazine microparticles |
04/23/2014 | EP2720684A2 A sustained-release composition containing peptides as active ingredient |
04/23/2014 | CN103748220A Bacteriocin derived from lactobacillus rhamnosus |
04/23/2014 | CN103748109A Glucagon/glp-1 receptor co-agonists |
04/23/2014 | CN103748107A Pseudomonas exotoxin a with less immunogenic t cell and/or b cell epitopes |
04/23/2014 | CN103747806A Non-peptidyl polymer-insulin multimer and method for producing same |
04/23/2014 | CN103747796A Method for treatment of autonomic nervous system disorders |
04/23/2014 | CN103747795A Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1 |
04/23/2014 | CN103747793A Composition containing soy protein hydrolyzate |
04/23/2014 | CN103747791A Honey composition with l-alanyl- l- glutamine |
04/23/2014 | CN103747780A Aqueous solutions of lipophilic substances, in particular medicinal solutions |
04/23/2014 | CN103740792A Preparation method of Sinonovacula constricta polypeptide with antioxidation function and application thereof |
04/23/2014 | CN103740730A Optimized king cobra venom protease inhibitor gene OH-TCI as well as expression method and application thereof |
04/23/2014 | CN103740658A Viperin, and preparation and application of viperin |
04/23/2014 | CN103739716A Fused polypeptide with function of protecting dynamic equilibrium of nerve cell mitochondria and application thereof |
04/23/2014 | CN103739714A TNF alpha and DC-SIGN fusion protein and application thereof |
04/23/2014 | CN103739713A New lung-oncocyte-apoptosis inducing fusion protein and application thereof |
04/23/2014 | CN103739712A Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
04/23/2014 | CN103739699A Recombinant sika deer cartialgenous thymosin beta4 as well as preparation method and use thereof |
04/23/2014 | CN103739698A Sika deer antler thymosin beta10 recombinant protein, preparation method and application of protein |
04/23/2014 | CN103739696A Cynoglossus semilaevis female specificity CSW3 protein as well as gene and application thereof |
04/23/2014 | CN103739693A Pinctada martensii meat antioxidant peptide sequence with antioxidant activity and application of Pinctada martensii meat antioxidant peptide sequence |
04/23/2014 | CN103739690A Method for separation preparation of anti-tumor polypeptide compound from ArcainflataReeve, and uses of anti-tumor polypeptide compound |
04/23/2014 | CN103739684A Preparation method and application of ganoderma atrum fungal immunomodulatory protein |
04/23/2014 | CN103739680A Polypeptides capable of inhibiting focal adhesion kinase and application thereof |
04/23/2014 | CN103739678A Polypeptides capable of inhibiting focal adhesion kinase and application thereof |
04/23/2014 | CN103739677A Polypeptide capable of inhibiting nuclear factor-kappaB and application thereof |
04/23/2014 | CN103739676A Application of polypeptide capable of inhibiting immunoglobulin K light chain gene enhancer in medicaments for treating acute inflammation |
04/23/2014 | CN103739674A Protamine mimic peptide series with low molecular and application thereof |
04/23/2014 | CN103739673A Polyethyleneglycol-modified polypeptide capable of inhibiting interleukin-6 and application thereof |
04/23/2014 | CN103739672A Polyethylene glycol modified polypeptide inhibiting VEGFR2 (vascular endothelial growth factor receptor2) tyrosine kinase and application thereof |
04/23/2014 | CN103739671A Polyethyleneglycol-modified polypeptide capable of inhibiting nuclear factor-kappaB and application thereof |
04/23/2014 | CN103739670A Polyethylene glycol modified polypeptide for inhibiting tumor necrosis factor-alpha and application of polypeptide |
04/23/2014 | CN103739669A Polypeptide capable of inhibiting interleukin-6 and application thereof |
04/23/2014 | CN103739666A Dipeptide QE with dual functions of lowering blood pressure and lowering blood fat and application thereof |
04/23/2014 | CN103739665A Dipeptide TE with dual functions of lowering blood pressure and lowering blood fat and application thereof |
04/23/2014 | CN103739591A 7-(3-acylamino-4-oxyiminomethyl-1-piperidyl) fluoroquinolone carboxylic acid and preparation method thereof |
04/23/2014 | CN103736103A Cancer suppressor gene ATOH8 and application of encoding protein thereof |
04/23/2014 | CN103736095A Chinese and western medicine combination preparation and application thereof to preparation of drugs for treating male and female reproduction diseases |
04/23/2014 | CN103736085A Medicament for preventing and treating alzheimer disease |
04/23/2014 | CN103736084A Composite lysozyme oral spray and preparation method thereof |
04/23/2014 | CN103736083A Composition for detoxifying, beautifying and slimming |
04/23/2014 | CN103736082A Combination of an insulin and a glp-1 agonist |
04/23/2014 | CN103736081A Application of ONTAK in preparing medicine for eliminating latent HIV (Human Immunodeficiency Virus) |
04/23/2014 | CN103736080A Preparation used for healing wound, preparation method and application thereof |
04/23/2014 | CN103736079A Vegetable oil body gel containing EGF (Epidermal Growth Factor) |
04/23/2014 | CN103736078A mPEG (Ethyl Glycolate)-HM-3 polypeptide lyophilized powder injection preparation as well as preparation method and application thereof |
04/23/2014 | CN103736077A Dipeptide ES with double functions of lowering blood pressure and lowering blood fat and application thereof |
04/23/2014 | CN103736076A Dipeptide DL with double functions of lowering blood pressure and lowering blood fat and application thereof |
04/23/2014 | CN103736075A Zinc-selenium tablet and application of Baofukang suppository to preparing medicine for treating senile vaginitis in combination with zinc-selenium tablet |
04/23/2014 | CN103736074A Bone mineral density increase health capsule and preparation method thereof |
04/23/2014 | CN103735699A Traditional Chinese medicinal composition for treating scald and preparation method thereof |
04/23/2014 | CN103735508A Polymyxin lipidosome and preparation process thereof |
04/23/2014 | CN103735495A Ciclosporin eye gel and preparation method thereof |
04/23/2014 | CN103734746A Use of aspartate for regulating glucose levels in blood |
04/23/2014 | CN103102403B Two mutants of analgesic bioactive peptide GRR, and preparation and application thereof |
04/23/2014 | CN102993289B Scolopendra mutilans polypeptide toxin kappa-SLPTX-Ssm4a and gene and application thereof |
04/23/2014 | CN102813907B Medicine composition for treating cerebrovascular accident sequela and preparation method and application thereof |
04/23/2014 | CN102805858B High-efficiency calcium supplement capsule and preparation method thereof |
04/23/2014 | CN102659930B High-purity cyclopeptide crystal and its preparation method and use |
04/23/2014 | CN102585013B Fusion protein containing omega interferon and method for preparing same |
04/23/2014 | CN102552916B New use of sodium salicylate |
04/23/2014 | CN102471371B Homing peptide for tumor vasculature |
04/23/2014 | CN102133416B Compound protein air-purifying deodorizer (deodorant liquid) |
04/23/2014 | CN101889024B FVIII peptides and their use in tolerising haemophiliacs |
04/23/2014 | CN101842112B Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium |
04/23/2014 | CN101842107B Antimicrobial peptide, compositions , and methods of use |
04/23/2014 | CN101835793B Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies |
04/23/2014 | CN101801406B Tissue kallikrein for the treatment of diseases associated with amyloid protein |
04/23/2014 | CN101678074B Novel use of ec-sod and method for preparing thereof |
04/23/2014 | CN101605900B Lactococcus promoters and uses thereof |